Taekwang Industrial Co. Ltd. Overview
Taekwang Industrial is the listed flagship of the Taekwang Group and one of Korea's oldest synthetic-fibre and petrochemical producers. It was the first Korean company to commercialise spandex, in 1979, and it remains a leading domestic acrylonitrile (AN) supplier from its Ulsan complex. Its legacy portfolio of purified terephthalic acid (PTA), acrylonitrile, sodium cyanide, acrylic fibre, nylon filament and spandex has been hit by Chinese overcapacity. The result is four consecutive annual operating losses (FY2022–FY2025) and revenue shrinking from about KRW 2.6 trillion to KRW 1.83 trillion. Its financial character is the opposite of distressed: it holds about KRW 1.5 trillion in net cash and liquid securities and almost no debt, and it carries a large equity-method stake of about 28% direct (about 45% group-wide) in Lotte Home Shopping. Since mid-2025 management has pursued a KRW 1.5 trillion "survival" restructuring into K-beauty, healthcare, hotels and real estate, under intense activist scrutiny over governance and minimal shareholder returns.
Company's own description
Taekwang describes itself as a vertically integrated producer spanning petrochemical raw materials through finished fibre and yarn. Third-party profiles drawn from its filings describe the business as petrochemicals, synthetic fibres, textiles and advanced materials, sold in Korea and internationally (S&P/Simply Wall St description).
Petrochemical products: purified terephthalic acid (PTA), propylene, acrylonitrile (AN), sodium cyanide (NaCN), acetonitrile, ammonium sulphate and hydrogen peroxide.
Synthetic fibres: acrylic fibre, nylon filament, spandex, spun yarns and low-melting fibre (the LMF line has since been exited).
Other materials: polyester fabrics and aramid fibre.
Non-manufacturing activities: property rental and a broadcasting/communications activity.
In its 29 September 2025 shareholder letter, then-CEO Yoo Tae-ho framed the company as standing at a crossroads between "elimination or leap" (paraphrased). The letter set two strategic axes:
-
Strengthen the existing business through "selection and concentration": prune loss-making lines and expand proven high-margin specialties such as modacrylic, aramid and NaCN.
-
Build a new portfolio in K-beauty, real-estate development, hotels and energy.
Reported segments
| Segment | Share of consolidated revenue (2Q26) |
|---|---|
| Manufacturing & Leasing | About 94% |
| Broadcasting & Telecommunications | About 6% |
On a consolidated basis, Taekwang reports two operating segments:
Source: Butler.works summary of the 2Q26 report.
Business and revenue model
Taekwang's revenue is almost entirely product revenue from commodity and semi-specialty chemicals and fibres, plus minor rental and broadcasting/telecom income. There are no subscription or licensing streams of note.
A large share of economic earnings comes from below the operating line:
-
equity-method income from associates, chiefly Lotte Home Shopping;
-
returns on a securities portfolio.
This explains why net income was positive in FY2022, FY2024 and FY2025 despite operating losses. For example, S&P data show equity-investment gains of KRW 229.3 bn in FY2024 and KRW 90.2 bn in FY2025.
Value-chain position
| Stage | Inputs bought | Products made and sold |
|---|---|---|
| Petrochemicals | Paraxylene, propylene and ammonia-type feedstocks (bought in) | PTA, used by polyester makers |
| — | — | AN, sold to ABS/NBL resin makers (LG Chem was a JV partner and offtaker) and used captively in acrylic fibre |
| Fibres | Captive or purchased intermediates | Acrylic, nylon and spandex for textile mills and apparel supply chains |
| Specialties | — | NaCN for gold mining; aramid for protective, optical-cable and rubber-reinforcement uses; modacrylic for wigs |
Taekwang sits in the midstream of the petrochemical-to-textile chain:
Customer types and end-markets
| End-market | Products | Customer type |
|---|---|---|
| Polyester chain (fibre, PET) | PTA | Polyester fibre/resin producers (B2B) |
| Plastics and synthetic rubber (appliances, autos, gloves) | AN | ABS/NBL producers (B2B) |
| Apparel, knitwear, sportswear | Acrylic, spandex, nylon filament | Spinners, knitters, weavers (B2B, export-heavy) |
| Hair goods (wigs, extensions) | Modacrylic | Wig manufacturers, mostly overseas |
| Gold mining | Sodium cyanide | Global miners and distributors |
| Defence, telecom, tyres | Aramid | Protective-gear, optical-cable and tyre/rubber makers |
| Electronics and chemical processing | Hydrogen peroxide, acetonitrile | Industrial users |
| Consumer beauty and household (from 2026, via associates) | Aekyung Industrial (2080 toothpaste, Kerasys) and Dongsung Pharmaceutical (Seven Eight hair dye, minoxidil) | Retail and online consumers |
| Hospitality | Courtyard by Marriott Seoul Myeongdong (group REIT) | Travellers |
Independent characterisation
Taekwang is best understood as three overlapping businesses:
-
A shrinking commodity manufacturer. Petrochemicals and fibres are structurally challenged by Chinese capacity additions.
-
A cash-rich holding vehicle. Book equity is about KRW 4.0 trillion, against a market value of about KRW 1.0 trillion. The balance sheet holds liquid assets, real estate (management cites over KRW 1 trillion of property value) and strategic stakes (Lotte Home Shopping, group financial affiliates).
-
An emerging consumer and real-estate platform built through 2025–2026 M&A.
The equity story is dominated by governance: the controlling family's influence, persistent sub-1% dividend payout, a 24.41% treasury-share block, and the question of whether acquisitions serve minority shareholders or family succession.
Strategy
Stated strategy (themes, paraphrased from the Sep 2025 letter, Apr 2026 letter and Jun 2026 value-up plan)
-
Crossroads framing. Management argues the company must restructure or decline because of Chinese overcapacity, raw-material volatility and slowing global demand.
-
Selection and concentration in the core. Exit low-return lines (PTA Plant 2, LMF, cotton spinning, China spandex, some nylon) and expand proven high-margin specialties (modacrylic, aramid, NaCN).
-
New growth axes. K-beauty and healthcare (Aekyung, Dongsung, SIL), real-estate development and hotels (Marriott Myeongdong), and energy (self-supply first, then energy-business revenue, aligned with carbon-neutrality and EU green trends).
-
Capital allocation. "All-in" investment of about KRW 1.5 tn across 2025–2026, while maintaining a no-borrowing stance as far as possible.
-
Communication. More shareholder letters, an upgraded ESG Support Office, and board-centred management.
Strategic initiatives, last 24 months
| Initiative | Date | Scope / target | Status (Oct 2026) |
|---|---|---|---|
| KRW 1.5 tn restructuring investment roadmap | 1 Jul 2025 | About KRW 1 tn in 2025, the rest in 2026; cosmetics, energy, real estate | About KRW 884 bn deployed in Aekyung, Marriott and Dongsung (Dealsite) |
| Existing-business reinvestment | Jul 2025 | Over KRW 500 bn planned for petrochemicals and fibres | Capex KRW 151.8 bn in FY2025 |
| Reserve operating fund | Jul 2025 | KRW 560 bn (3.5 years of operating needs) ring-fenced | Policy |
| Treasury-share EB (KRW 318.6 bn) | 27 Jun 2025 | 3-year, 0% coupon, exchange price KRW 1,172,251 | Withdrawn 24 Nov 2025 |
| China exit | Jul 2025–Jun 2026 | Halt and sell the Changshu spandex plant | Completed (sold CNY 143 m) |
| Articles amendment | 1 Oct 2025 | About 10 new business purposes added (cosmetics, real estate, hotels, energy, REIT/PFV investment, blockchain finance) | Completed |
| K-beauty entry | Oct 2025–Mar 2026 | Aekyung acquisition; SIL launch | Closed |
| Healthcare/derma | Jan–May 2026 | Dongsung Pharmaceutical rescue | Rehabilitation exit under way |
| Hotel/real estate | Dec 2025 | Courtyard Marriott Seoul (KRW 254.2 bn) | Closed |
| Shipbuilding | Nov 2025–present | K Shipbuilding bid | First process failed Jun 2026; rebid under review (Sep 2026) |
| Financial expansion (group) | 2025–2026 | IGIS AM (failed); KDB Life (Heungkuk Life final bid Aug 2026) | KDB pending |
| ESG governance upgrade | 2,025 | ESG team raised to an office | Completed |
| 2026 Corporate Value Enhancement Plan | 30 Jun 2026 | 2030 revenue KRW 5 tn; ROE 8%; treasury shares as M&A currency; treasury holding/disposal plan to the 2027 AGM | Criticised by Truston |
Medium-term targets and guidance
| Target | Baseline (FY2025) | 2030 target | Source |
|---|---|---|---|
| Revenue | About KRW 1.8 tn | KRW 5 tn | Value-up plan (NewDaily, Jul 2026) |
| ROE | About 2% | 8% | Same |
| Dividend payout | About 1% | No quantified target (Truston demands 10% in 2026 rising to 40% by 2030) | Edaily |
| Treasury shares | 24.41% held | Holding/disposal plan to be put to the 2027 AGM | Edaily (Sep 2026) |
No annual earnings guidance is published.
Products & Services
Pricing is not publicly disclosed for any product; all are sold at negotiated or market-index prices.
Petrochemicals
| Product | Description and key characteristics | Target customer | Capacity, latest data | Status |
|---|---|---|---|---|
| Purified terephthalic acid (PTA) | Main raw material for polyester fibre and PET resin, made from paraxylene | Polyester fibre/film/resin producers | — | Petrochemical plant No. 2 shut in 2025 amid Chinese oversupply |
| Acrylonitrile (AN) | Monomer for ABS, NBL (nitrile gloves), acrylic fibre and carbon fibre | Resin makers (formerly LG Chem offtake), captive acrylic fibre | 290 kt/yr at Ulsan Plant 3, plus TL Chemical's planned 260 kt/yr | Domestic share 33.3% (2019, KPIA handbook) |
| Sodium cyanide (NaCN) | AN co-product chain derivative; leaching reagent for gold mining | Global gold miners | Expansion "accelerating" (Sep 2025 letter) | Growth specialty |
| Acetonitrile | AN co-product; solvent for pharma and electronics | Pharma/electronics solvent users | — | Ongoing |
| Ammonium sulphate | AN co-product; fertiliser | Fertiliser distributors | — | Ongoing |
| Hydrogen peroxide (H2O2) | Oxidant and bleach; electronic grades used in semiconductors | Pulp/paper, textiles, electronics | — | Ongoing |
| Propylene | Olefin feedstock | Internal use and merchant sale | — | Ongoing |
Synthetic fibres and textiles
| Product | Description and key characteristics | Target customer | Notes |
|---|---|---|---|
| Spandex ("ACELAN" brand) | Elastane fibre for stretch apparel, hosiery and medical textiles | Knitters/weavers, global apparel supply chain | Korea's first (1979). China plant closed 2025; Korean production continues |
| Acrylic fibre | Wool-substitute staple and tow for knitwear and blankets | Spinners and knitwear makers | Backward-integrated with captive AN |
| Modacrylic | Flame-retardant acrylic copolymer used as wig and hair-extension fibre | Wig manufacturers (Africa/US demand) | Growth specialty per the Sep 2025 letter |
| Nylon filament | Nylon 6 filament yarn for apparel | Weavers/knitters | Some nylon lines flagged for shutdown (Jul 2025) |
| Aramid fibre | High-strength para-aramid for ballistic/protective gear, optical-cable strength members and rubber reinforcement | Defence/protective, telecom cable, tyre makers | Expansion under way (Sep 2025 letter) |
| Polyester fabrics | Including black abaya fabric for Middle East markets | Middle East apparel wholesalers | Ongoing |
| Spun yarn / cotton yarn | Cotton spinning | Weavers | Cotton-spinning mill withdrawn (Sep 2025 letter) |
| Low-melting fibre (LMF) | Bicomponent binder fibre for nonwovens | Nonwoven and automotive felt makers | Exited 2025 |
| Raincoats, umbrellas, safety clothing | Historical wet-weather and safety apparel lines (Wikipedia) | Consumers/industry | — |
Leasing and real estate
| Asset | Description | Notes |
|---|---|---|
| Property rental | Rental of owned real estate; management cites over KRW 1 tn of real-estate value | Truston alleges KRW 301.2 bn was spent on real-estate-related ventures over two years, including the Dosan Park building (KRW 20 bn) |
| Courtyard by Marriott Seoul Myeongdong (formerly Namdaemun) | 4-star, 400 rooms, opened 2016; bought from KT&G for KRW 254.2 bn via a Heungkuk REIT vehicle | Management calls it the starting point of a real-estate development axis |
Consumer, beauty and healthcare (new, 2026)
| Business | Flagship brands and products | Notes |
|---|---|---|
| Aekyung Industrial (31.56%) | 2080 (toothpaste), Kerasys (shampoo), Spark (detergent), AGE20's and Luna (cosmetics) | Over 20 years of uninterrupted profit and about KRW 50 bn annual EBITDA (Dealsite, Sep 2025). Q2 2026 OP KRW 4.5 bn (-59.4% YoY); overseas sales share 42% |
| Dongsung Pharmaceutical (consortium) | Jeongrohwan (antidiarrhoeal), Seven Eight (hair dye), minoxidil (hair-loss treatment), Phonozen (photodynamic anti-cancer candidate in Phase 2) | Plan described as a "total beauty-healthcare platform" with Aekyung |
| SIL | Cosmetics brand company | Reported target: derma-cosmetics in the mould of APR's "medicube" (Dealsite, Jan 2026) |
Broadcasting and telecommunications
A residual segment providing about 6% of revenue. Product detail is not disclosed in the sources reviewed.
Financial Narrative
Source for all tables: S&P Global Market Intelligence via StockAnalysis.com (consolidated, KRW M, FY Jan–Dec). Ratios and per-share values are derived by this analyst. Per-share values use about 841,631 outstanding shares (ex-treasury), implied by dividends paid ÷ KRW 1,750.
Income statement
Notes:
Net income: shown is total net income. Attributable-to-parent figures per Butler.works are KRW 318.4 bn, 342.2 bn, -14.7 bn, 218.4 bn and 83.1 bn (KRW 100M basis: 3184, 3422, -147, 2184, 831), which conflict slightly with S&P.
Diluted EPS: equals basic: no dilutive instruments are outstanding after the 2025 EB withdrawal.
DPS: is derived from cash dividends paid (KRW 1,473 M per year for FY2022–FY2025) and the KRW 1,750 FY2025 dividend confirmed by StockHub/Wisesheets (ex-date 30 Mar 2026). The FY2021 dividend is assumed at KRW 1,750 based on the FY2022 cash payment.
Revenue CAGR FY2021–FY2025: -8.4% a year.
Commentary. FY2021 was a super-cycle peak: post-COVID restocking and record spreads in AN and spandex delivered a 13.7% operating margin and a record KRW 355 bn operating profit (company-reported). From 2022, Chinese capacity additions in PTA, spandex and acrylics compressed spreads to near zero:
-
gross margin collapsed to 3.8% in FY2022;
-
the company posted operating losses in four consecutive years (company basis).
FY2024 showed partial gross-margin recovery (9.4%) from cost cuts and the end of loss-making lines. FY2025 revenue fell another 9.9% as PTA plant No. 2 and the LMF line closed. SG&A rose 14% on restructuring and new-business costs, driving a -2.0% operating margin.
Net income has been decoupled from operations: equity-method gains (Lotte Home Shopping and other associates) and portfolio returns turned operating losses into net profits in FY2022 and FY2024. FY2025 net income of KRW 80.8 bn included a KRW 42.2 bn asset write-down and restructuring charge.
Q1 2026 revenue was KRW 533.3 bn with an operating loss of KRW 11.4 bn (Sateconomy, Jun 2026). TTM revenue to March 2026 was KRW 1.873 tn with an operating loss of KRW 56.2 bn (S&P), so losses persisted into 2026.
Balance sheet
Commentary. The balance sheet is exceptionally conservative. Management describes 75 years of a "no-borrowing principle" (Sep 2025 letter).
Debt: fell to KRW 9.1 bn at end-FY2025 after KRW 168.7 bn of short-term debt was repaid.
Liquidity: cash plus liquid securities of about KRW 1.55 tn equals about 39% of equity.
Book value: BVPS of about KRW 4.67 m against a share price of about KRW 0.9 m explains the 0.2x P/B.
FY2024 investments: long-term investments dropped by about KRW 745 bn while other long-term assets rose by about KRW 600 bn. This reflects reclassification of the SK Broadband stake to held-for-sale, sold in May 2025 for about KRW 777.6 bn (Dealsite).
FY2025 working capital: jumped to KRW 2.03 tn as sale proceeds were parked in short-term financial products (KRW 818 bn at 1H25 per Dealsite).
2026 outlook: cash deployment of about KRW 884 bn across Aekyung, the Marriott hotel and Dongsung (Dealsite) will reduce liquidity during 2026.
Cash flow
Commentary. Operating cash flow is volatile and was negative in FY2025 (-KRW 133 bn), driven by:
-
non-cash equity gains reversing out (-KRW 90 bn);
-
working-capital build: inventory +KRW 40 bn and other net operating assets -KRW 52 bn;
-
KRW 90.5 bn of cash taxes, likely on the SK Broadband gain.
Capex doubled to KRW 151.8 bn in FY2025. Specialty expansions (aramid, NaCN, modacrylic) and construction in progress rising to KRW 198 bn (from KRW 93 bn) are the drivers. TTM operating cash flow to June 2026 was -KRW 281.5 bn and TTM FCF -KRW 463.6 bn, signalling continued cash burn in the core business.
Shareholder returns are negligible. Dividends of about KRW 1.47 bn a year equal roughly 0.1% of book equity, and no buybacks or cancellations have occurred in five years.
Key ratios (derived)
Notes: the FY2022 net-debt/EBITDA figure is computed on negative EBITDA and is not meaningful (company-basis EBITDA was also negative). The ROIC approximation uses a 24.2% tax rate for FY2021; negative-OI years are shown pre-tax. All ratios use year-end balances.
Commentary. Ratios portray a company that is financially impregnable but economically under-earning.
ROE: has averaged about 4% over five years, of which roughly two-thirds came from associates and securities rather than operations. Management's own 2030 target of 8% ROE is below Korea's typical cost of equity, as Truston argues.
Asset turnover: has eroded from 0.53x to 0.41x as revenue shrank while the asset base stayed mostly intact.
Working capital: the cash conversion cycle widened to 62 days in FY2025 on the inventory build.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Detail
Segment Overview
| Segment | Contents | Products/services | Approx. share of revenue (2Q26) |
|---|---|---|---|
Manufacturing & Leasing | Petrochemical and fibre manufacturing at Ulsan; property leasing | PTA, AN, NaCN, acetonitrile, ammonium sulphate, H2O2, propylene; acrylic, modacrylic, nylon filament, spandex, aramid, polyester fabric; rental income | 94% |
Broadcasting & Telecommunications | Residual broadcasting/communications activity within the consolidated group (the cable-TV business T-broad was historically sold to SK Broadband) | Broadcasting/telecom services | 6% |
Revenue by Segment and Revenue by Segment (KRW)
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Consolidated revenue, S&P (KRW Mn) | 2,591,846 | 2,606,596 | 2,265,490 | 2,027,535 | 1,827,440 |
Consolidated operating income, S&P (KRW Mn) | 353,931 | -104,478 | -99,370 | -395 | -36,015 |
Consolidated revenue, company-reported per Korean media (KRW 100M) | 25,918 | 27,038 | 21,263 | 20,275 | 18,274 |
Consolidated operating income, company-reported per Butler.works (KRW 100M) | 3,553 | -1,221 | -994 | -272 | -360 |
Product Group Details
| Product group | Approx. share | Approx. revenue (KRW 100M) | YoY | Comment |
|---|---|---|---|---|
Petrochemicals | 76% | 13,900 | -16% | PTA, AN, NaCN and derivatives |
Fibres | 13% | 2,400 | -5% | Acrylic, modacrylic, nylon, spandex, aramid |
Other (leasing, broadcasting/telecom) | About 11% | — | — | Residual |
“—” = not publicly disclosed.
Group Entities
| Entity | Relationship | Activity | Status |
|---|---|---|---|
TL Chemical Co., Ltd. | 100% subsidiary since Dec 2025 (60% from 2021) | Acrylonitrile production, Ulsan | Bought out LG Chem's 40% (1.48 m shares) for about KRW 49.1 bn |
Taekwang Synthetic Fiber (Changshu) Co., Ltd. | Former 100% subsidiary | Spandex, China | Halted 2025; sold Jun 2026 for CNY 143 m |
Lotte Home Shopping (Woori Home Shopping) | Associate: Taekwang 27.99% direct; group about 45% with Daehan Synthetic Fiber 10.21% and Tcis 6.78% | TV home shopping | Board reshaped to 6 Lotte : 3 Taekwang (Mar 2026) |
Aekyung Industrial (KRX: 018250) | 31.56% held directly; co-controlled with "Beauty Life One" SPC (T2 PE/Yuanta), also 31.56% | Household and cosmetics (2080, Kerasys, AGE20's, Luna) | Closed 26 Mar 2026 |
Dongsung Pharmaceutical (KRX: 002210) | Member of the UAMCO-led consortium holding 72.45% | OTC drugs, hair dye, hair-loss care | Rehabilitation-exit process (spring 2026) |
SIL (실) | Newly established cosmetics subsidiary | K-beauty brand vehicle | Established 2025 |
TRN Co. | Taekwang holds 3.32% | Group de facto holding company (Lee Ho-jin 51.83%, Lee Hyun-joon 39.36%) | — |
Koryo Savings Bank | Taekwang 20.2% (2021 data) | Savings bank | — |
T2 Private Equity (reported) | Taekwang 41%, Tcis 41%, Lee Hyun-joon 9%, Lee Hyun-na 9% (per CEO Score Daily) | PE GP used in group deals | Governance concern raised by Truston and the press |
Income Statement and Margin Analysis (%)
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Revenue (KRW Mn) | 2,591,846 | 2,606,596 | 2,265,490 | 2,027,535 | 1,827,440 |
Revenue growth (%) | 48.9 | 0.6 | -13.1 | -10.5 | -9.9 |
Cost of revenue (KRW Mn) | 2,032,419 | 2,507,494 | 2,163,152 | 1,836,152 | 1,652,022 |
Gross profit (KRW Mn) | 559,428 | 99,103 | 102,338 | 191,383 | 175,417 |
SG&A (KRW Mn) | 182,136 | 177,962 | 166,110 | 160,479 | 183,293 |
Operating income (KRW Mn) | 353,931 | -104,478 | -99,370 | -395 | -36,015 |
Depreciation & amortisation (KRW Mn) | 57,970 | 60,142 | 66,068 | 42,872 | 40,673 |
EBITDA, OI + D&A (KRW Mn) | 411,901 | -44,336 | -33,302 | 42,477 | 4,658 |
Gain on equity investments (KRW Mn) | 37,558 | 317,139 | 157,846 | 229,279 | 90,182 |
Net income (KRW Mn) | 316,364 | 256,658 | -18,502 | 214,531 | 80,824 |
EPS, basic, derived (KRW) | 375,894 | 304,953 | -21,983 | 254,899 | 96,033 |
EPS, diluted (KRW) | 375,894 | 304,953 | -21,983 | 254,899 | 96,033 |
Dividend per share (KRW) | 1,750 | 1,750 | 1,750 | 1,750 | 1,750 |
Gross margin (%) | 21.6 | 3.8 | 4.5 | 9.4 | 9.6 |
Operating margin (%) | 13.7 | -4.0 | -4.4 | 0.0 | -2.0 |
EBITDA margin (%) | 15.9 | -1.7 | -1.5 | 2.1 | 0.3 |
Net margin (%) | 12.2 | 9.8 | -0.8 | 10.6 | 4.4 |
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansBalance Sheet and Per-Share Data
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Total assets (KRW Mn) | 4,922,462 | 4,820,744 | 4,738,292 | 4,722,278 | 4,498,283 |
Cash & equivalents (KRW Mn) | 356,851 | 477,540 | 336,621 | 390,360 | 426,477 |
Cash + short-term investments + trading securities (KRW Mn) | 1,454,274 | 1,241,362 | 1,265,624 | 1,434,372 | 1,549,600 |
Long-term investments (KRW Mn) | 1,681,992 | 1,867,664 | 1,902,863 | 1,157,607 | 1,259,398 |
Short-term debt incl. current leases (KRW Mn) | 101,145 | 81,130 | 85,888 | 93,195 | 4,359 |
Long-term debt incl. leases (KRW Mn) | 11,784 | 7,017 | 13,844 | 7,121 | 4,774 |
Total debt (KRW Mn) | 112,928 | 88,147 | 99,732 | 100,316 | 9,133 |
Net cash, positive = net cash (KRW Mn) | 1,341,346 | 1,153,216 | 1,165,892 | 1,334,055 | 1,540,467 |
Total equity (KRW Mn) | 3,970,913 | 4,122,700 | 4,029,499 | 4,015,567 | 3,964,265 |
Goodwill + intangibles (KRW Mn) | 61,034 | 25,133 | 23,644 | 20,497 | 18,337 |
Working capital (KRW Mn) | 1,580,159 | 1,509,274 | 1,432,365 | 1,562,877 | 2,030,079 |
Book value per share (KRW) | 4,625,193 | 4,804,970 | 4,689,721 | 4,668,610 | 4,669,556 |
Treasury stock (KRW Mn) | -284,629 | -284,629 | -284,629 | -284,629 | -284,629 |
Cash Flow and Margin Analysis (%)
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Operating cash flow (KRW Mn) | 289,591 | -146,338 | 106,938 | 228,719 | -133,280 |
Capital expenditure (KRW Mn) | -85,096 | -61,812 | -78,513 | -79,166 | -151,845 |
Free cash flow (KRW Mn) | 204,495 | -208,150 | 28,425 | 149,552 | -285,124 |
FCF margin (%) | 7.9 | -8.0 | 1.3 | 7.4 | -15.6 |
Dividends paid (KRW Mn) | -1,304 | -1,473 | -1,473 | -1,473 | -1,473 |
Share buybacks (KRW Mn) | 0 | 0 | 0 | 0 | 0 |
Net debt issued/(repaid) (KRW Mn) | -18,075 | -32,067 | -11,178 | -10,512 | -91,727 |
Investing cash flow (KRW Mn) | -233,400 | 296,869 | -237,498 | -165,359 | 313,680 |
Cash income tax paid (KRW Mn) | 13,597 | 103,436 | -10,156 | 9,351 | 90,451 |
Returns & Leverage Ratios (%) and Financial Ratios (x)
| Ratio | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
ROE (%) | 8.0 | 6.2 | -0.5 | 5.3 | 2.0 |
ROA (%) | 6.4 | 5.3 | -0.4 | 4.5 | 1.8 |
ROIC, approx., NOPAT/(equity + debt - liquid assets) (%) | 10.2 | -4.0 | -3.6 | 0.0 | -1.1 |
Current ratio (x) | 3.66 | 4.60 | 4.41 | 4.88 | 7.26 |
Debt/equity (%) | 2.8 | 2.1 | 2.5 | 2.5 | 0.2 |
Net debt/EBITDA (x, negative = net cash) | -3.3 | -26.0 | -35.0 | -31.4 | -330.7 |
Interest coverage, OI/cash interest (x) | 254.4 | -52.1 | -20.2 | -0.1 | -8.7 |
Asset turnover (x) | 0.53 | 0.54 | 0.48 | 0.43 | 0.41 |
Days sales outstanding | 67.4 | 56.3 | 65.0 | 62.5 | 65.7 |
Days inventory outstanding | 35.7 | 35.3 | 25.3 | 29.5 | 41.6 |
Days payables outstanding | 50.4 | 32.3 | 38.8 | 40.5 | 45.0 |
Cash conversion cycle (days) | 52.7 | 59.3 | 51.5 | 51.5 | 62.3 |
Product Lines
| Product line | Principal geographies (qualitative) | Direction | Driver |
|---|---|---|---|
PTA | Korea and Asian polyester hubs | Declining | Chinese self-sufficiency; plant No. 2 closure |
AN | Korea (ABS/NBL makers), Asia exports | Stable to declining | Chinese AN capacity additions; LG Chem exit from the JV |
Spandex | Korea and formerly China (Changshu) | Sharply declining (China) | China plant losses of KRW 93.5 bn over 3 years; closure 2025 |
Modacrylic (wig fibre) | Export: Africa, North America hair-goods markets | Growing | Specialty demand cited by management |
NaCN | — | Growing | Gold-price strength, geopolitical safe-haven demand (Sep 2025 letter) |
Aramid | Global defence, telecom and tyre supply chains | Growing | Defence spending; optical-cable demand |
Polyester fabric (abaya) | Middle East | — | — |
Aekyung (associate) | Korea plus overseas (42% overseas in Q2 2026; global sales +35% YoY) | Growing overseas | K-beauty exports |
Share Price History
| Date | Price (KRW) | Source |
|---|---|---|
27 Jun 2025 | 1,103,000 | Dealsite (EB pricing day) |
4 Jul 2025 | About 1,091,000 (intraday) | Asia Business Daily |
Mid-Sep 2025 | About 932,000 | Hanwha Investment & Securities table |
13 Nov 2025 | About 860,000 (intraday high) | Chosun via TechLeap |
16 Jul 2026 | 866,000 | StockAnalysis |
24 Jul 2026 | 891,000 | HALO |
6 Aug 2026 | 913,000 | StockAnalysis |
4 Sep 2026 | 901,000 | ValueLine |
16 Sep 2026 | 908,000 | StockAnalysis |
Valuation Multiples
| Multiple | Taekwang | Peer comparison |
|---|---|---|
P/E (TTM) | About 7.9–8.8x | — |
P/B | About 0.22–0.25x | KOSPI average about 1x (context) |
EV/EBITDA | Not meaningful: EV is negative (net cash exceeds market cap) and EBITDA is near zero; HALO shows -274x | n/m |
EV/Sales | Negative EV, so not meaningful | n/m |
Dividend yield | About 0.2% | — |
Per-Share Data and Dividends & Capital Returns
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Dividend per share (KRW) | 1,750 | 1,750 | 1,750 | 1,750 | 1,750 |
Total dividends paid (KRW Mn) | 1,304 | 1,473 | 1,473 | 1,473 | 1,473 |
Payout ratio (%) | 0.4 | 0.6 | -8.0 | 0.7 | 1.8 |
Capital Markets
| Item | Detail |
|---|---|
Buybacks | None in five years; no current authorisation identified |
Treasury shares | 24.41%; EB monetisation withdrawn Nov 2025; holding/disposal plan to the 2027 AGM; value-up plan contemplates use as M&A currency |
Credit ratings (Moody's, S&P, Fitch) | None; no rated public debt |
Debt maturity profile | Total debt KRW 9.1 bn (FY2025), mostly leases (current KRW 3.5 bn; long-term KRW 4.8 bn); maturity risk negligible |
Analyst consensus | No sell-side consensus identified. Individual brokers (e.g., Hanwha Investment & Securities) publish occasional notes. |
Index / liquidity | KOSPI constituent; extreme illiquidity (free float about 230k shares) |
Analyst Conclusions
Guidance and consensus
Management guidance: only long-range targets of KRW 5 tn revenue and 8% ROE by 2030 (Value-Up Plan, 30 Jun 2026). No annual guidance.
Consensus: not available.
Implied trajectory: reaching KRW 5 tn from about KRW 1.8 tn would require about 22% annual growth. That is only achievable through large consolidated acquisitions (e.g., shipbuilding or insurance-adjacent assets) rather than organic growth.
Bull case
-
Deep asset discount. At about 0.23x book, with net cash and liquid securities of about KRW 1.54 tn exceeding the about KRW 1.0 tn market cap, investors effectively pay less than zero for the operating businesses, the Lotte Home Shopping stake and real estate. Any credible capital-return commitment, such as treasury cancellation at the 2027 AGM, could trigger a sharp re-rating.
-
Core losses are narrowing structurally. Exiting the worst assets (China spandex with KRW 93.5 bn of 3-year losses, PTA Plant 2, LMF) and redeploying capex into aramid, modacrylic and NaCN could return manufacturing to break-even or profit by 2027.
-
Regulatory tailwinds. Korea's Commercial Act reforms and value-up programme, plus persistent activist pressure, raise the probability of better shareholder returns over time.
Bear case
-
Capital misallocation. Cash is flowing into diversified acquisitions with uncertain synergies. Aekyung's value dropped below its purchase price within months, and shipbuilding and insurance bids risk deploying further multi-hundred-billion-won sums, which TTM FCF of -KRW 463.6 bn makes more acute.
-
Governance discount is entrenched. The family's control (about 40% plus 24.41% treasury), the around 1% payout, the owner's legal issues and alleged family-benefiting deal structures make the discount sticky regardless of fundamentals.
-
No end to commodity pressure. Chinese overcapacity is structural, and the shrinking revenue base plus low R&D leave little moat in remaining lines.
Key catalysts and monitorables (next 12 months)
| Catalyst | Timing | Why it matters |
|---|---|---|
| K Shipbuilding rebid follow-up disclosure | From 6 Oct 2026 | Possible capital commitment of up to about KRW 900 bn |
| KDB Life outcome (Heungkuk Life) | H2 2026 | Group leverage and intra-group funding risk |
| Truston actions (EGM request, derivative suit) | Q4 2026 | Governance escalation |
| Q3 2026 results | Nov 2026 | Whether core losses are narrowing |
| Lotte Home Shopping litigation | Ongoing | Value of a key associate stake |
| Lee Ho-jin criminal proceedings | Ongoing | Governance and reputation |
| Treasury-share plan and 2027 AGM proposals | Early 2027 | Single largest potential re-rating lever |
| Specialty capacity start-ups (aramid, NaCN, modacrylic) | 2026–2027 | Margin recovery |
| Aekyung and Dongsung turnaround metrics | Quarterly | Validation of the beauty pivot |
| Third Commercial Act amendment (mandatory treasury cancellation) | Legislative calendar | Could force cancellation of the 24.41% block |
Analyst verdict
Taekwang Industrial presents one of the starkest value-versus-governance dilemmas on the Korean exchange.
The balance sheet is formidable. About KRW 1.54 trillion of net cash and liquid securities and almost no debt support roughly KRW 4.0 trillion of book equity. Against that, the market assigns a capitalisation of only about KRW 1.0 trillion. By any conventional measure the stock trades below liquidation value.
The operating franchise has deteriorated sharply. Revenue has shrunk by about 30% since 2021, and four straight years of operating losses reflect a structural rather than cyclical squeeze from Chinese overcapacity. Management's response has two halves:
-
pruning legacy capacity and leaning into defensible niches (aramid, modacrylic, sodium cyanide), which is rational and overdue;
-
a parallel, rapid-fire diversification into beauty, pharmaceuticals, hotels, shipbuilding and group financial assets, which is far more contentious.
Early evidence is not encouraging. Aekyung's price had to be cut after a product recall, and its market value then fell well below the acquisition price. The K Shipbuilding process collapsed. The IGIS bid failed. Meanwhile, trailing free cash flow is deeply negative.
Governance is the decisive variable. A controlling family with a convicted, pardoned and reportedly re-indicted former chairman as "adviser" retains a 24.41% treasury block. Payout has averaged about 1% for a decade. Deal structures include vehicles part-owned by the founder's children. Until the board demonstrably aligns capital allocation with minority shareholders, the asset discount is likely to persist. The levers would be treasury-share cancellation, a credible payout path and transparent, arm's-length M&A.
Verdict. Taekwang is a deep-value, governance-contingent situation, not a fundamental growth story. Investors with a long horizon and tolerance for illiquidity may find the downside cushioned by net cash. However, the catalysts for value realisation sit largely outside management's demonstrated priorities: the 2027 AGM treasury-share plan, regulatory change, or activist litigation. Pending clearer evidence that new acquisitions earn their cost of capital and that capital will be returned, the appropriate stance is cautious neutrality, with an emphasis on monitoring governance catalysts over operating ones.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansExecutive Leadership
Executive Leadership Team
| Name | Title | Tenure / appointment | Background | Compensation |
|---|---|---|---|---|
Lee Bu-ui (이부의) | Co-CEO; Head of Existing Business (business division general manager) | Appointed business head 2025; inside director from 1 Oct 2025 EGM; co-CEO from 1 Apr 2026 | Long experience in petrochemicals and fibres (Sep 2025 letter) | Not publicly disclosed (in verifiable form) |
Jeong In-cheol (정인철) | Co-CEO; Head of Future Business | Recruited 2025 as VP heading the new Future Business Promotion Office; CEO from 1 Apr 2026 | Led new-business discovery and investment across industries (Sep 2025 letter); sits on Aekyung's board | — |
Yoo Tae-ho (유태호) | Former CEO (signed Sep 2025 letter) | — | Press describes him as Lee Ho-jin's "right hand" (Dealsite headline) | — |
Lim Jeong-gyo (임정교) | Managing Director, Head of ESG Support Office | Appointed 2025 when the ESG team was upgraded | Finance and compliance background | — |
Lee Ho-jin (이호진) | Non-standing adviser; former Group Chairman | Adviser since after the 2023 pardon | Convicted of embezzlement (released 2021, pardoned 2023); declined to register as a director in 2026, citing health. Press reports a new indictment on embezzlement/breach-of-trust charges in 2026 (Sateconomy, Jun 2026) | Not applicable |
“—” = not publicly disclosed.
Governance Overview
| Aspect | Detail |
|---|---|
Notable outside director | Prof. Kim Woo-jin (SNU Graduate School of Business; governance specialist), nominated by Truston and appointed via the 2024 AGM as audit committee member |
Independence | An outside-director majority is required for large KOSPI companies. Truston disputes substantive independence. |
Group Management Council | An informal group-level body. Truston (Sep 2026) questions its influence over Taekwang's decisions and CEO appointments, and whether Lee Ho-jin attends or receives reports. |
Board & Management Changes
| Date | Change | Context |
|---|---|---|
| 2025 | Future Business Promotion Office created; Jeong In-cheol hired | Restructuring programme |
| 2025 | Lee Bu-ui appointed business head | Turnaround of existing businesses |
1 Oct 2025 | Lee Bu-ui elected inside director (EGM) | — |
1 Apr 2026 | Co-CEO system: Jeong In-cheol plus Lee Bu-ui | The day after the AGM defeated activist proposals |
Major Shareholders
| Holder | Stake | Source / date |
|---|---|---|
Lee Ho-jin (former chairman) | 29.48% | — |
TRN Co. (Lee family company) | 11.22% | Dealsite (2021) |
Treasury shares | 24.41% (271,769 shares) | Multiple, 2025–2026 |
Truston Asset Management | 5.97% (2024); 5.95% (Mar 2025) | Asia Business Daily; Dealsite |
Free float | About 230,000 shares (about 20% of issued) | Truston (Jul 2026) |
Competitive Landscape
Competitors by Segment
| Product line | Competitor | Country | Positioning vs Taekwang |
|---|---|---|---|
Spandex | Hyosung TNC (creora) | Korea | Global #1 spandex; far larger scale |
Spandex | Zhejiang Huafon Chemical | China | Low-cost Chinese leader; key source of overcapacity |
Spandex | Xinxiang Chemical Fiber | China | Chinese scale producer |
Aramid | Hyosung Advanced Materials (ALKEX) | Korea | Domestic aramid peer |
Aramid | Kolon Industries (Heracron) | Korea | Leading Korean para-aramid producer |
Aramid | DuPont (Kevlar), Teijin (Twaron) | US / Japan | Global incumbents |
Acrylic / modacrylic | Aksa Akrilik | Turkey | World's largest acrylic fibre producer |
Acrylic / modacrylic | Kaneka (Kanekalon) | Japan | Modacrylic wig-fibre leader |
AN | Tongsuh Petrochemical | Korea | Main domestic AN competitor |
AN | INEOS Nitriles, Asahi Kasei, Chinese producers | Global | Scale and technology leaders |
PTA | Hanwha TotalEnergies, Hanwha Solutions; Chinese majors (Hengli, Rongsheng/Yisheng) | Korea / China | Chinese mega-scale has collapsed margins |
NaCN | Cyanco, Orica, Draslovka, Australian Gold Reagents | US / Australia / Czechia | Global mining-chemical suppliers |
Polyester / industrial fibre | Huvis | Korea | Domestic polyester fibre peer |
Household & beauty (via Aekyung) | Amorepacific, LG H&H, APR | Korea | Aekyung is a mid-tier challenger |
Competitor Detail
| Metric | Taekwang (FY2025) |
|---|---|
Revenue | KRW 1.83 tn |
Revenue growth | -9.9% |
Operating margin | -2.0% |
R&D intensity | About 0.01% (S&P line item) |



